反応 #52935
ord-cde8ff367da34073a090ca5d91002c80
反応方程式
反応物
試薬
溶媒
反応条件
詳細条件
See reaction.notes.procedure_details.
後処理
- 1その他DMF was removed
- 2その他the residue was partitioned between water and EtOAc
- 3その他The organic layer was separated
- 4抽出the aqueous solution was extracted with EtOAc
- 5抽出The combined extract
- 6乾燥was dried (MgSO4)
- 7その他evaporated
- 8その他The residue was purified by preparative TLC (silica gel; eluent: hexanes/CH2Cl2/EtOAc, 3:3:1)
実験手順
To a suspension of N-(tert-butoxycarbonyl)-4-(2,6-dichlorobenzyloxy)-3-hydroxy-L-phenylalanine methyl ester (0.45 g), K2CO3 (0.199 g), and n-Bu4NI (0.035 g) in DME (4.0 mL) was added CH3I (0.072 mL) and the mixture was stirred overnight at room temperature. DMF was removed and the residue was partitioned between water and EtOAc. The organic layer was separated and the aqueous solution was extracted with EtOAc. The combined extract was dried (MgSO4) and evaporated. The residue was purified by preparative TLC (silica gel; eluent: hexanes/CH2Cl2/EtOAc, 3:3:1) to yield 0.396 g of N-(tert-butoxycarbonyl)-4-(2,6-dichlorobenzyloxy)-3-methoxy-L-phenylalanine methyl ester. ESMS: m/z 484 (MH+).